Montepio, Melanie R.

HRN: 28-56-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/13/2026
02/23/2026
PO
380mg
Q8h
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines